表紙
市場調査レポート

特発性肺高血圧症:世界の治験レビュー

Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 314736
出版日 ページ情報 英文 76 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
特発性肺高血圧症:世界の治験レビュー Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014
出版日: 2014年09月21日 ページ情報: 英文 76 Pages
概要

当レポートでは、特発性肺高血圧症に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • 特発性肺高血圧症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:心血管疾患の治験における特発性肺高血圧症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:心血管疾患の治験における特発性肺高血圧症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

特発性肺高血圧症の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • United Therapeutics Corporation
    • Actelion Ltd
    • Pfizer Inc.
    • Northern Therapeutics, Inc.
    • Mast Therapeutics, Inc.
    • GlaxoSmithKline plc
    • Bayer AG
  • 代表的な研究機関・病院の治験の概要
    • Masih Daneshvari Hospital
    • Royal Prince Alfred Hospital
    • Tehran University of Medical Sciences
    • Medizinische Hochschule Hannover
    • Columbia University
    • VU University Medical Center
    • Imperial College London
    • University of Pennsylvania
    • Stanford University

5つの代表的な治験のプロファイル

付録

目次

GlobalData's clinical trial report, "Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Idiopathic Pulmonary Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Idiopathic Pulmonary Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Idiopathic Pulmonary Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Idiopathic Pulmonary Hypertension
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Idiopathic Pulmonary Hypertension
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • United Therapeutics Corporation
      • Clinical Trial Overview of United Therapeutics Corporation
      • Actelion Ltd
      • Clinical Trial Overview of Actelion Ltd
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Northern Therapeutics, Inc.
      • Clinical Trial Overview of Northern Therapeutics, Inc.
      • Mast Therapeutics, Inc.
      • Clinical Trial Overview of Mast Therapeutics, Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
    • Clinical Trial Overview of Top Institutes / Government
      • Masih Daneshvari Hospital
      • Clinical Trial Overview of Masih Daneshvari Hospital
      • Royal Prince Alfred Hospital
      • Clinical Trial Overview of Royal Prince Alfred Hospital
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • Medizinische Hochschule Hannover
      • Clinical Trial Overview of Medizinische Hochschule Hannover
      • Columbia University
      • Clinical Trial Overview of Columbia University
      • VU University Medical Center
      • Clinical Trial Overview of VU University Medical Center
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • Stanford University
      • Clinical Trial Overview of Stanford University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Region, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Idiopathic Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Northern Therapeutics, Inc., 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mast Therapeutics, Inc., 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Masih Daneshvari Hospital, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Prince Alfred Hospital, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medizinische Hochschule Hannover, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*

List of Figures

  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Idiopathic Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top